Vitrolife AB Stock Nasdaq Stockholm
Stocks
SE0000816043
Medical Equipment, Supplies & Distribution
OTC Markets Traded| Market Cap | 12.47B 1.27B 1.11B 1.04B 948M 1.78B 121B 1.78B 4.81B 61.89B 4.76B 4.66B 200B | P/E 2026 * |
25.3x | P/E 2027 * | 20.5x |
|---|---|---|---|---|---|
| Enterprise Value | 13.02B 1.32B 1.15B 1.09B 990M 1.86B 127B 1.86B 5.02B 64.62B 4.97B 4.86B 209B | EV / Sales 2026 * |
3.77x | EV / Sales 2027 * | 3.36x |
| Free-Float |
54.39% | Yield 2026 * |
1.2% | Yield 2027 * | 1.37% |
Last Transcript: Vitrolife AB
| 1 day | -0.18% |
| Manager | Title | Age | Since |
|---|---|---|---|
Bronwyn O'Connor
CEO | Chief Executive Officer | 52 | 01/08/2023 |
Pär Ihrskog
DFI | Director of Finance/CFO | 55 | 10/10/2025 |
Nicklas Hansen
CIO | Chief Investment Officer | 40 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Pia Marions
BRD | Director/Board Member | 63 | 19/04/2013 |
| Chairman | 70 | 01/08/2023 | |
| Chairman | 55 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.18% | -6.68% | - | - | 1.27B | |
| +2.34% | +1.37% | +197.87% | +586.71% | 23.33B | |
| +3.42% | +10.57% | +530.79% | +98.92% | 10.31B | |
| +1.31% | +0.62% | -35.80% | -19.45% | 9.76B | |
| +5.14% | +12.91% | -2.31% | - | 8.66B | |
| -0.04% | -0.53% | +99.96% | +62.08% | 6.55B | |
| +0.86% | +1.92% | -27.31% | -20.73% | 5.76B | |
| -2.31% | +2.70% | -2.56% | -11.97% | 4.43B | |
| +0.89% | +8.70% | +66.62% | +72.10% | 4B | |
| +7.53% | +10.21% | -13.10% | -24.70% | 2.77B | |
| Average | +1.92% | +6.53% | +90.46% | +92.87% | 8.4B | |
| Weighted average by Cap. | +2.22% | +6.17% | +138.08% | +223.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.46B 352M 307M 289M 263M 493M 33.68B 494M 1.33B 17.16B 1.32B 1.29B 55.37B | 3.71B 377M 329M 310M 282M 529M 36.11B 529M 1.43B 18.4B 1.42B 1.38B 59.36B |
| Net income | 493M 50.08M 43.66M 41.13M 37.45M 70.22M 4.8B 70.31M 190M 2.44B 188M 184M 7.89B | 609M 61.9M 53.97M 50.83M 46.29M 86.79M 5.93B 86.9M 235M 3.02B 233M 227M 9.75B |
| Net Debt | 549M 55.83M 48.68M 45.85M 41.75M 78.28M 5.35B 78.38M 212M 2.72B 210M 205M 8.79B | -26.74M -2.72M -2.37M -2.23M -2.03M -3.81M -260M -3.82M -10.31M -133M -10.21M -9.99M -428M |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
